Riggs P. Non-medical use and abuse of commonly prescribed medications. Curr Med Res Opin. 2008;24:869–77.[CrossRef]
Substance Abuse and Mental Health Services Administration. Results from the 2006 National Survey on Drug Use and Health: national findings. NSDUH series H-32. DHHS publication no. SMA 07-4293. Rockville, MD: Office of Applied Studies; 2007.
Wasan AD, Correll DJ, Kissin I, et al. Iatrogenic addiction in patients treated for acute or subacute pain: a systematic review. J Opioid Manag. 2006;2:16–22.
Cicero TJ, Dart RC, Inciardi JA, et al. The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS). Pain Med. 2007;8:157–70.
Inciardi JA, Surratt HL, Cicero TJ, Beard RA. Prescription opioid abuse and diversion in an urban community: the results of an ultrarapid assessment. Pain Med. 2009;10:537–48.
Baldisseri MR. Impaired healthcare professional. Crit Care Med. 2007;35:S106–16.
Merlo LJ, Gold MS. Prescription opioid abuse and dependence among physicians: hypotheses and treatment. Harvard Rev Psychiatry. 2008;16:181–94.
Lord S, Downs G, Furtaw P, et al. Nonmedical use of prescription opioids and stimulants among student pharmacists. J Am Pharm Assoc. 2009;49:519–28.
Trinkoff AM, Zhou Q, Storr CL, Soeken KL. Workplace access, negative proscriptions, job strain, and substance use in registered nurses. Nurs Res. 2000;49:83–90.
Hughes PH, Storr CL, Brandenburg N, et al. Physician substance use by medical specialty. J Addict Dis. 1999;18:23–37.
Bennet J, O'Donovan D. Substance misuse by doctors, nurses and other healthcare workers. Curr Opin Psychiatry. 2001;14:195–9.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed., text revision (DSM-IV-TR). Washington, DC: American Psychiatric Association; 2000.
Crawford NS. The road to recovery: training to help the impaired pharmacist. Am Pharm. 1991;NS31(5):33–8.
Baldwin JN, Light K, Stock C, et al. Curricular guidelines for pharmacy education: substance abuse and addictive disease. Am J Pharm Educ. 1991;55:311–6.
Baldwin JN. The addicts among us. Am J Pharm Educ. 2009;73:1–2.
Kenna GA, Wood MD. Prevalence of substance use by pharmacists and other health professionals. J Am Pharm Assoc. 2004;44:684–93.
McAuliffe WE, Santangelo SL, Gingras J, et al. Use and abuse of controlled substances by pharmacists and pharmacy students. Am J Hosp Pharm. 1987;44:311–7.
Normack JW, Eckel FM, Pfifferling J, Cocolas G. Impairment risk in North Carolina pharmacists. Am Pharm. 1985;NS25:45–8.
Dabney DA. Onset of illegal use of mind-altering or potentially addictive prescription drugs among pharmacists. J Am Pharm Assoc. 2001;41:392–400.
Miller CJ, Banahan BF. A comparison of alcohol and illicit drug use between pharmacy students and the general college population. Am J Pharm Educ. 1990;54:27–30.
Kriegler KA, Baldwin JN, Scott DM. A study of alcohol and other drug use behaviors and risk factors in health profession students. J Am Coll Health. 1994;42:259–65.
Baldwin JN, Scott DM, Agrawal S, et al. Assessment of alcohol and other drug use behaviors in health professions students. Subst Abus. 2006;27:25–35.
National Association of Retail Druggists. NARD's guide to programs for the impaired pharmacist. Alexandria, VA: National Association of Retail Druggists; 1988.
Reimer C, Jurkat H, Maeculen B, Stetter F. Quality of life and health behavior of physicians with and without substance abuse [article in German]. Psychotherapeut. 2001;46:376–85.
Kenna GA, Wood MD. Substance use by pharmacy and nursing practitioners and students in a northeastern state. Am J Health Syst Pharm. 2004;61:921–30.
Bender DE, Ewbank D. The focus group as a tool for health research: issues in design and analysis. Health Trans Rev. 1994;4:63–79.
Strauss A, Corbin J. Basics of qualitative research: theory, procedures, and techniques. Newbury Park, CA: Sage; 1990.
McAuley JW, Akers AL. Assessing the impact of a substance abuse educational program on pharmacy students’ knowledge base: a controlled study. Am J Pharm Educ. 1999;63:309–14.
Busto U, Knight K, Janecek E, et al. A problem-based learning course for pharmacy students on alcohol and psychoactive substance abuse disorders. Am J Pharm Educ. 1994;58:56–60.
Graham AW, Pfeifer J, Trumble J, Nelson ED. A pilot project: continuing education for pharmacists on substance abuse prevention. Subst Abus. 1999;20:33–43.
Tucker DR, Gurnee MC, Sylvestri MF, et al. Psychoactive drug use and impairment markers in pharmacy students. Am J Pharm Educ. 1988;52:42–6.
Szeinbach SL, Banahan BF. Pharmacy students’ attitudes toward the need for university implemented policies regarding alcohol and illicit drug use. Am J Pharm Educ. 1990;54:155–8.
Baldwin JN, Scott-Jungnickel PW, Narducci WA, Prokop PA. Evaluation of alcohol and drug use attitudes and behaviors in pharmacy college faculty. Part II: attitudes. Am J Pharm Educ. 1990;54:239–42.
Lafferty L, Hunter TS, March WA. Knowledge, attitudes and practices of pharmacists concerning prescription drug abuse. J Psychoactive Drugs. 2006;38:229–32.
Baldwin JN, Dole EJ, Levine PJ, et al. Survey of pharmacy substance abuse course content. Am J Pharm Educ. 1994;58(suppl):47S–52S.
National Center on Addiction and Substance Abuse at Columbia University. Under the counter: the diversion and abuse of controlled prescription drugs in the U.S. New York: Columbia University; 2005.
Bissell L, Haberman PW, Williams RL. Pharmacists recovering from alcohol and other drug addictions: an interview study. Am Pharm. 1989;NS29:19–30.
Dabney DA, Hollinger RC. Illicit prescription drug use among pharmacists: evidence of a paradox of familiarity. Work Occup. 1999;26:77–106.
Chi J. Impaired pharmacists: more programs move to handle the problem. Drug Topics. 1983;127:24–29.
Epstein D. Theft: how safe are your pharmacies? Part I: the chains. Drug Topics. 1990;130:12–23.
Epstein D. Theft: how safe are your pharmacies? Part II: the independents. Drug Topics. 1990;131:13–25.
Hankes L, Bissell L. Health professionals. In: Lowinson JH, Eds. Substance abuse: a comprehensive textbook. 2nd ed. Baltimore, MD: Williams & Wilkins; 1992:897–908.
Gallegos KV, Veit FW, Wilson PO, et al. Substance abuse among health professionals. Maryland Med J. 1988;37:191–7.
Dole EJ, Tommasello AC. Recommendations for implementing effective substance abuse education in pharmacy practice. In: Haack MR, Eds. Strategic planning for interdisciplinary faculty development: arming the national health professional workforce for a new approach to substance use disorders. Providence, RI: Association for Medical Education and Research in Substance Abuse; 2002:263–71.
Cobaugh DJ. Pharmacists’ role in preventing and treating substance abuse: why are we doing so little? Am J Health Syst Pharm. 2003;60:1947.
Levy S. Beware the dark side of pharmacy life. Drug Topics. 2002;13:33.
Prince VT. Advancing to the next level: a look at PRNs 20 years later. J Am Pharm Assoc. 2002;42:4–5.
Young D. Recovery assistance programs help pharmacists with substance abuse problems. Am J Health Syst Pharm. 2003;60(24):2544, 2547–8.